Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00572
|
|||||
| Drug Name |
Chloroquine
|
|||||
| Synonyms |
(+)-Chloroquine; (-)-Chloroquine; (R)-(-)-Chloroquine; 3377 RP opalate; 7-Chloro-4-((4-(diethylamino)-1-methylbutyl)amino)quinoline; 7-Chloro-4-[[4-(diethylamino)-1-methylbutyl]amino]quinoline; Amokin; Aralen; Aralen HCl; Arechin; Arechine; Arequin; Arolen; Arthrochin; Artrichin; Avlochlor; Avloclor; Bemaco; Bemaphate; Bemasulph; Benaquin; Bipiquin; CU-01000012392-2; Capquin; Chemochin; Chingamin; Chloraquine; Chlorochin; Chlorochine; Chlorochinum; Chloroin; Chloroquin; Chloroquina; Chloroquine (USP/INN); Chloroquine (VAN); Chloroquine Bis-Phosphoric Acid; Chloroquine FNA (TN); Chloroquine [USAN:INN:BAN]; Chloroquine phosphate; Chloroquinium; Chloroquinum; Chloroquinum [INN-Latin]; Chlorquin; Cidanchin; Clorochina; Clorochina [DCIT]; Cloroquina; Cloroquina [INN-Spanish]; Cocartrit; Dawaquin (TN); Delagil; Dichinalex; Elestol; Gontochin; Gontochin phosphate; Heliopar; Imagon; Ipsen 225; Iroquine; Khingamin; Klorokin; Lapaquin; Malaquin; Malaquin (*Diphosphate*); Malaren; Malarex; Mesylith; Miniquine; N4-(7-Chloro-4-quinolinyl)-N1,N1-diethyl-1,4-pentanediamine; N4-(7-chloroquinolin-4-yl)-N1,N1-diethylpentane-1,4-diamine; Neochin; Nivachine; Nivaquine B; Pfizerquine; Quinachlor; Quinagamin; Quinagamine; Quinercyl; Quingamine; Quinilon; Quinoscan; RP 3377; RP-3377; Resochen; Resochin; Resochin (TN); Resoquina; Resoquine; Reumachlor; Reumaquin; Rivoquine; Ro 01-6014/N2; Ronaquine; Roquine; SN 6718; SN-7618; ST 21; ST 21 (pharmaceutical); Sanoquin; Silbesan;Siragan; Solprina; Sopaquin; Tanakan; Tanakene; Tresochin; Trochin; W 7618;WIN 244; {4-[(7-chloroquinolin-4-yl)amino]pentyl}diethylamine
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Malaria [ICD11: 1F40] | Approved | [1] | |||
| Therapeutic Class |
Antimalarials
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C18H26ClN3
|
|||||
| Canonical SMILES |
CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl
|
|||||
| InChI |
InChI=1S/C18H26ClN3/c1-4-22(5-2)12-6-7-14(3)21-17-10-11-20-18-13-15(19)8-9-16(17)18/h8-11,13-14H,4-7,12H2,1-3H3,(H,20,21)
|
|||||
| InChIKey |
WHTVZRBIWZFKQO-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 54-05-7
|
|||||
| Pharmaceutical Properties | Molecular Weight | 319.9 | Topological Polar Surface Area | 28.2 | ||
| Heavy Atom Count | 22 | Rotatable Bond Count | 8 | |||
| Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 3 | |||
| XLogP |
4.6
|
|||||
| PubChem CID | ||||||
| PubChem SID |
10526125
, 11335579
, 11360818
, 11363006
, 11365568
, 11368130
, 11371321
, 11373917
, 11376292
, 11404351
, 11405289
, 11461790
, 11466576
, 11467696
, 11483910
, 11486252
, 11487943
, 11490157
, 11492094
, 11493946
, 11528736
, 14776983
, 26675665
, 29221876
, 447935
, 46506925
, 47217037
, 47291356
, 47440521
, 47440522
, 47885638
, 48035387
, 48110720
, 48185227
, 48259487
, 49635547
, 49681217
, 49698849
, 49846799
, 50111008
, 5050990
, 53787949
, 53788124
, 56310729
, 57321414
, 596572
, 7849425
, 7978921
, 8151759
, 9827
|
|||||
| ChEBI ID |
ChEBI:3638
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | MATE1 | Transporter Info | Multidrug and toxin extrusion protein 1 | Substrate | [2] | |
| P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [3] | ||
| References | ||||||
| 1 | Chloroquine was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | Molecular mechanism of renal tubular secretion of the antimalarial drug chloroquine. Antimicrob Agents Chemother. 2011 Jul;55(7):3091-8. | |||||
| 3 | Improving the prediction of the brain disposition for orally administered drugs using BDDCS. Adv Drug Deliv Rev. 2012 Jan;64(1):95-109. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.